09:59 AM EST - Microbix Biosystems Inc. : Has begun a build-out of its second facility that is initially intended to support a tenfold increase of production capacity for its QAPs™ quality assessment products – which support the accuracy of clinical laboratory testing including, but not limited to, support for tests for the SARS-CoV-2 virus causing COVID-19 disease. Microbix Biosystems Inc.
shares T.MBX are trading up $0.005 at $0.35.
